Free Trial
→ June 12: $100 Turns Into $100,000? (From Brownstone Research) (Ad)tc pixel Free EDEN Stock Alerts

Eden Research (EDEN) Competitors

Eden Research logo
GBX 3.32 -0.05 (-1.49%)
As of 11:40 AM Eastern
Compare

EDEN vs. WYN, DNK, PHC, EML, and KRPZ

Should you buy Eden Research stock or one of its competitors? MarketBeat compares Eden Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Eden Research include Wynnstay Group (WYN), Danakali (DNK), Plant Health Care (PHC), Emmerson (EML), and Kropz (KRPZ). These companies are all part of the "agricultural inputs" industry.

How does Eden Research compare to Wynnstay Group?

Wynnstay Group (LON:WYN) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Wynnstay Group has a beta of 0.175, indicating that its share price is 83% less volatile than the broader market. Comparatively, Eden Research has a beta of 1.762, indicating that its share price is 76% more volatile than the broader market.

Wynnstay Group currently has a consensus price target of GBX 450, suggesting a potential upside of 25.00%. Given Wynnstay Group's stronger consensus rating and higher possible upside, analysts clearly believe Wynnstay Group is more favorable than Eden Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wynnstay Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Eden Research
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Wynnstay Group has a net margin of 0.39% compared to Eden Research's net margin of -65.01%. Wynnstay Group's return on equity of 1.70% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Wynnstay Group0.39% 1.70% 2.08%
Eden Research -65.01%-20.99%-11.29%

5.9% of Wynnstay Group shares are owned by institutional investors. Comparatively, 10.0% of Eden Research shares are owned by institutional investors. 4.1% of Wynnstay Group shares are owned by company insiders. Comparatively, 3.2% of Eden Research shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Wynnstay Group has higher revenue and earnings than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Wynnstay Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wynnstay Group£583.44M0.14£6.20M£9.5937.54
Eden Research£3.62M7.37-£1.52M-£0.44N/A

In the previous week, Eden Research had 1 more articles in the media than Wynnstay Group. MarketBeat recorded 1 mentions for Eden Research and 0 mentions for Wynnstay Group. Wynnstay Group's average media sentiment score of 0.00 equaled Eden Research'saverage media sentiment score.

Company Overall Sentiment
Wynnstay Group Neutral
Eden Research Neutral

Summary

Wynnstay Group beats Eden Research on 11 of the 15 factors compared between the two stocks.

How does Eden Research compare to Danakali?

Eden Research (LON:EDEN) and Danakali (LON:DNK) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Danakali has a net margin of 0.00% compared to Eden Research's net margin of -65.01%. Danakali's return on equity of 0.00% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Danakali N/A N/A N/A

Danakali has lower revenue, but higher earnings than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Danakali, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M7.37-£1.52M-£0.44N/A
Danakali£67.50K0.00N/A-£1.10N/A

In the previous week, Eden Research had 1 more articles in the media than Danakali. MarketBeat recorded 1 mentions for Eden Research and 0 mentions for Danakali. Eden Research's average media sentiment score of 0.00 equaled Danakali'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Danakali Neutral

10.0% of Eden Research shares are held by institutional investors. 3.2% of Eden Research shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Eden Research beats Danakali on 6 of the 9 factors compared between the two stocks.

How does Eden Research compare to Plant Health Care?

Eden Research (LON:EDEN) and Plant Health Care (LON:PHC) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Eden Research has higher earnings, but lower revenue than Plant Health Care. Eden Research is trading at a lower price-to-earnings ratio than Plant Health Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M7.37-£1.52M-£0.44N/A
Plant Health Care£11.21M0.00-£4M-£0.01N/A

In the previous week, Eden Research had 1 more articles in the media than Plant Health Care. MarketBeat recorded 1 mentions for Eden Research and 0 mentions for Plant Health Care. Eden Research's average media sentiment score of 0.00 equaled Plant Health Care'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Plant Health Care Neutral

10.0% of Eden Research shares are held by institutional investors. Comparatively, 24.0% of Plant Health Care shares are held by institutional investors. 3.2% of Eden Research shares are held by company insiders. Comparatively, 72.2% of Plant Health Care shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Eden Research has a beta of 1.762, suggesting that its share price is 76% more volatile than the broader market. Comparatively, Plant Health Care has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Plant Health Care has a net margin of -35.69% compared to Eden Research's net margin of -65.01%. Eden Research's return on equity of -20.99% beat Plant Health Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Plant Health Care -35.69%-40.17%-20.92%

Summary

Eden Research beats Plant Health Care on 6 of the 11 factors compared between the two stocks.

How does Eden Research compare to Emmerson?

Eden Research (LON:EDEN) and Emmerson (LON:EML) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Eden Research has higher revenue and earnings than Emmerson. Eden Research is trading at a lower price-to-earnings ratio than Emmerson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M7.37-£1.52M-£0.44N/A
EmmersonN/AN/A-£4.50M-£2.27N/A

In the previous week, Eden Research had 1 more articles in the media than Emmerson. MarketBeat recorded 1 mentions for Eden Research and 0 mentions for Emmerson. Eden Research's average media sentiment score of 0.00 equaled Emmerson'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Emmerson Neutral

10.0% of Eden Research shares are owned by institutional investors. Comparatively, 6.6% of Emmerson shares are owned by institutional investors. 3.2% of Eden Research shares are owned by insiders. Comparatively, 7.5% of Emmerson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Eden Research has a beta of 1.762, indicating that its stock price is 76% more volatile than the broader market. Comparatively, Emmerson has a beta of 1.327, indicating that its stock price is 33% more volatile than the broader market.

Emmerson has a net margin of 0.00% compared to Eden Research's net margin of -65.01%. Eden Research's return on equity of -20.99% beat Emmerson's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Emmerson N/A -15,494.59%-7.75%

Summary

Eden Research beats Emmerson on 7 of the 11 factors compared between the two stocks.

How does Eden Research compare to Kropz?

Kropz (LON:KRPZ) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

10.0% of Eden Research shares are held by institutional investors. 3.8% of Kropz shares are held by insiders. Comparatively, 3.2% of Eden Research shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Kropz has a beta of -0.1, suggesting that its stock price is 110% less volatile than the broader market. Comparatively, Eden Research has a beta of 1.762, suggesting that its stock price is 76% more volatile than the broader market.

In the previous week, Eden Research had 1 more articles in the media than Kropz. MarketBeat recorded 1 mentions for Eden Research and 0 mentions for Kropz. Kropz's average media sentiment score of 0.00 equaled Eden Research'saverage media sentiment score.

Company Overall Sentiment
Kropz Neutral
Eden Research Neutral

Eden Research has lower revenue, but higher earnings than Kropz. Eden Research is trading at a lower price-to-earnings ratio than Kropz, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kropz£38.52M0.53-£137.40M£0.781.66
Eden Research£3.62M7.37-£1.52M-£0.44N/A

Kropz has a net margin of -25.92% compared to Eden Research's net margin of -65.01%. Kropz's return on equity of -14.67% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Kropz-25.92% -14.67% -7.02%
Eden Research -65.01%-20.99%-11.29%

Summary

Kropz beats Eden Research on 7 of the 12 factors compared between the two stocks.

Get Eden Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDEN vs. The Competition

Export
MetricEden ResearchAgricultural Inputs IndustryMaterials SectorLON Exchange
Market Cap£26.63M£4.73B£4.83B£2.81B
Dividend YieldN/A2.44%5.00%6.08%
P/E Ratio-7.4811.0223.30365.78
Price / Sales7.37109.857,513.5188,200.18
Price / Cash11.9016.5727.2127.89
Price / Book1.391.096.827.74
Net Income-£1.52M£62.49M£157.24M£5.89B
7 Day Performance-2.47%-2.63%2.28%2.27%
1 Month Performance-6.09%-6.63%0.46%3.51%
1 Year Performance-17.06%16.93%76.97%79.62%

Eden Research Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDEN
Eden Research
N/AGBX 3.32
-1.5%		N/A-15.8%£26.63M£3.62MN/A19
WYN
Wynnstay Group
N/AGBX 374.42
+1.2%		GBX 450
+20.2%		+12.2%£85.17M£583.44M39.04944
DNK
Danakali
N/AN/AN/AN/A£73.67M£67.50KN/A5,205
PHC
Plant Health Care
N/AN/AN/AN/A£32.50M£11.21MN/A56
EML
Emmerson
N/AGBX 2.16
-0.9%		N/A+16.9%£28.80MN/AN/A1,190

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:EDEN) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Elon Confirms SpaceX IPO For 6/12 [Act Now!]
Elon Musk has confirmed SpaceX will IPO on Friday, June 12, 2026, at a valuation of up to $2 trillion - potent...
Paradigm Press | Sponsoredtc pixel
I was right about SpaceX. Now here's the part that matters
Goldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...
The Oxford Club | Sponsoredtc pixel